4//SEC Filing
Insys Therapeutics, Inc. 4
Accession 0001209191-15-051961
CIK 0001516479operating
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 5:56 PM ET
Size
9.5 KB
Accession
0001209191-15-051961
Insider Transaction Report
Form 4
Del Fosse Franc
General Counsel
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2015-06-10−10,000→ 50,000 totalExercise: $13.27Exp: 2024-05-18→ Common Stock (10,000 underlying) - Sale
Common Stock
2015-06-10$34.48/sh−10,000$344,800→ 0 total - Exercise/Conversion
Common Stock
2015-06-10$13.27/sh+10,000$132,700→ 10,000 total
Footnotes (4)
- [F1]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.36 to $34.63 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]This option was previously reported as an option for 30,000 shares at an exercise price of $26.55 per share, but was adjusted to reflect the 2-for-1 forward stock split effected by the Issuer on June 5, 2015.
- [F3]The option vests in 48 equal monthly installments and will be fully vested and exercisable on May 19, 2018.
- [F4]On June 5, 2015, the Issuer effected a 2-for-1 forward stock split, resulting in the reporting person's ownership of 30,000 additional options.
Documents
Issuer
Insys Therapeutics, Inc.
CIK 0001516479
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001516479
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 5:56 PM ET
- Size
- 9.5 KB